Robalzotan (NAD-299), a novel selective 5-HT(1A) receptor antagonist

CNS Drug Reviews

Volumn 5, Issue 3, 1999, Pages 213-232

  Ross, Svante B ^a   Thorberg, Seth Olov ^a   Jerning, Eva ^a   Mohell, Nina ^a   Stenfors, Carina ^a   Wallsten, Carin ^a   Milchert, Ingalill Gagner ^a   Öjteg, Göran ^a,b  

^a Research and Development at Scania Technical Centre   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

5 HT(1A) receptor antagonist; Biochemistry; Metabolism; NAD 299; Pharmacokinetics; Pharmacology; Robalzotan

Indexed keywords

N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ROBALZOTAN; SEROTONIN 1A ANTAGONIST;

ANIMAL BEHAVIOR; AUTORADIOGRAPHY; BRAIN; CORTICOSTERONE RELEASE; DRUG RECEPTOR BINDING; EJACULATION; HYPOTHERMIA; ISOTOPE LABELING; LOCOMOTION; NONHUMAN; PHARMACODYNAMICS; POSITRON EMISSION TOMOGRAPHY; REVIEW;

EID: 0032725459     PISSN: 1080563X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-3458.1999.tb00101.x     Document Type: Review

References (55)

1. 1A receptors. Chichester: Elis Horwood, 1987:185-198.
2. Ahlenius S, Salmi P, Henriksson I. Effects of robalzotan on neostriatal rate of serotonin and dopamine synthesis in rats, normally and under psychomotor activation. Eur Neuropsychopharmacol 1998;8(Suppl2):S183.
3. 1A receptor antagonist, robalzotan, reverses the SSRI-induced inhibition of serotonergic cell firing in the dorsal raphe nucleus in the rat. Eur Neuropsychopharmacol 1998;8(Suppl 2):S180.
4. Arvidsson LE, Hacksell U, Nilsson JLG, et al. 8-Hydroxy-2-(di-n-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist. J Med Chem 1981;24:921-923.
5. Aulakh CS, Wozniak KM, Haas M, Hill JL, Zohar J, Murphy DL. Food intake, neuroendocrine and temperature effects of 8-OH-DPAT in the rat. Eur J Pharmacol 1988;146:253-259.
6. 2C receptors induces oxytocin release in the male rat. Brain Res 1993;611:330-332.
7. 1A receptors induces lower lip retraction in the rat. Pharmacol Biochem Behav 1989;33:821-827.
8. 1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: Inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects. J Pharmacol Exp Ther 1991;258:58-65.
9. Blier P, deMontigny C. Current psychiatric uses of drugs acting on the serotonin system. In: Baumgarten HG, Göthert M, eds. Serotoninergic neurons and 5-HT receptors in the CNS. Handbook of experimental pharmacology. Vol 129. Berlin: Springer, 1997:727-750.
10. 1A receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes. J Pharmacol Exp Ther 1986;238:248-253.
11. Dourish CT, Hutson PH, Curzon G. Low doses of the putative serotonin agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) elicit feeding in the rat. Psychopharmacology (Berlin) 1985;86:197-204.
12. Evenden JL, Hammarberg EM, Hanson HS, et al. Novel (R)-5-carbamoyl-8-fluoro-3-N,N-disubstituted amino-3,4-dihydro-2H-1-benzopyrans. US patent WO-9,511,891. 1995.
13. 1A receptors in the monkey brain. Eur Neuropsychopharmacol 1998;8(Suppl 2):S168.
14. 1A receptor antagonist. Behav Brain Res 1996;73:337-353.
15. 1A receptor antagonist, WAY-100,635. Eur J Pharmacol 1995;281:81-88.
16. Gagner Milchert I, Berg A, Berin B, et al. Pharmacokinetics of robalzotan in rats and dogs including in vitro and in vivo data on metabolism. Eur Neuropsychopharmacol 1998;8(Suppl 2):S185.
17. Gagner Milchert I, Gabrielsson J, Lindhe J, Terelius Y. In vitro - in vivo extrapolation of robalzotan metabolic parameters: An interspecies comparison. Eur Neuropsychopharmacol 1998;8(Suppl 2):S184.
18. 2 receptors. Br J Pharmacol 1985;84:743-753.
19. 3H]PAT. Nature 1983;305:140-132.
20. 3H]NAD. Eur Neuropsychopharmacol 1998;8(Suppl 2):S17.
21. 11C]WAY-100,635. Brain Res 1997;745:96-108.
22. 3H]8-hydroxy-2-(di-n-propylamino)tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain. J Neurochem 1985;44:1685-1696.
23. Hartig PR. Molecular biology and transductional characteristics of 5-HT receptors. In: Baumgarten HG, Göthert M, eds. Serotoninergic neurons and 5-HT receptors in the CNS. Handbook of experimental pharmacology. Vol 129. Berlin: Springer, 1997:175-212.
24. 1B receptor agonists 8-OH-DPAT and anpirtoline, as evidenced by use of the corrsponding new and selective receptor antagonists NAD-299 and NAS-181. Br J Pharmacol 1998;125:1733-1743.
25. 1A-receptor antagonist. J Med Chem 1990;33:1541-1544.
26. Hjorth S. Hypothermia in the rat induced by the potent serotonergic agent 8-OH-DPAT. J Neural Transm 1985;61:131-135.
27. 1A receptor antagonist robalzotan. Eur Neuropsychopharmacol 1998;8(Suppl 2):S175.
28. Hjorth S, Carlsson A. Is pindolol a mixed agonist-antagonist at central serotonin (5-HT) receptors? Eur J Pharmacol 1986;129:131-138.
29. Hjorth S, Carlsson A, Lindberg P, et al. 8-Hydroxy-2-(dipropylamino)tetralin, 8-OH-DPAT, a potent and selective simplified ergot congener with central 5-HT-receptor stimulating activity. J Neural Transm 1982:55:169-188.
30. 1A agonists LY 165163 and 8-OH-DPAT is not prevented by 5-HT depletion. Eur J Pharmacol 1987;143:221-228.
31. 1A receptor antagonist robalzotan (NAD-299) in rats. Eur Neuropsychopharmacol 1998;8(Suppl 2):S168.
32. 2 and β-adrenergic receptors. Eur Neuropsychopharmacol 1998;8(Suppl 2):S208.
33. 1A receptor antagonist. Eur J Pharmacol 1998;360:219-225.
34. Johansson CE, Meyerson BJ, Höglund AU. The long-term effects of 8-hydroxy-2-(dipropyl-amino)tetralin (8-OH-DPAT) on copulatory and exploratory behaviour in male rats. Eur J Pharmacol 1990;178:1-9.
35. 1A receptor antagonist, NAD-299. J Pharmacol Exp Ther 1997;283:216-225.
36. Keane PE, Soubrié P. Animal models of integrated serotoninergic functions: their predictive value for the clinical applicability of drugs interfering with serotoninergic transmission. In: Baumgarten HG, Göthert M, eds. Serotoninergic neurons and 5-HT receptors in the CNS. Handbook of experimental pharmacology. Vol 129. Berlin: Springer, 1997:707-725.
37. 1A receptors increases release of prolactin in the rat. Neuropharmacology 1992;31:643-647.
38. Koenig JI, Meltzer HY, Gudelsky GA. Stimulation of corticosterone and β-endorphin secretion in the rat by selective 5-HT receptor subtype activation. Eur J Pharmacol 1987;137:1-8.
39. 1A receptor agonist 8-OH-DPAT. Neuropharmacology 1990;29:85-91.
40. 1A receptor antagonists. Eur J Pharmacol 1998;346:209-215.
41. 2) agonists and antagonists on renin and corticosterone secretion. Neuroendocrinology 1987;45:305-310.
42. 1A) receptor antagonists on dorsal raphe cell firing. J Pharmacol Exp Ther 1999;288:820-826.
43. Middlemiss DN. Blockade of central 5-HT autoreceptors by β-adrenoceptor antagonists. Eur J Pharmacol 1986;120:51-54.
44. 1 recognition sites. Eur J Pharmacol 1983;30:151-153.
45. 1A receptor activation. Br J Pharmacol 1992; 106:603-6.
46. 1A receptor antagonist robalzotan: General pharmacodynamic effects. Eur Neuropsychopharmacol 1998;8(Suppl 2):S145.
47. 1 receptors. Brain Res 1985;346:205-230.
48. Peroutka SJ, Snyder SH. Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding. Science 1980;210:88-90.
49. Rényi L, Archer T, Minor GG, Tandberg B, Fredriksson A, Ross SB. The inhibition of the cage-leaving response - a model for studies of the serotonergic neurotransmission in the rat. J Neural Transm 1986;65:193-210.
50. 1A selective agonists. Eur J Pharmacol 1986;128:295-298.
51. 1B agonists. Synapse 1987;1:3-9.
52. 3H]NAD-299. Naunyn Schmiedeberg's Arch Pharmacol 1998;357:500-507.
53. 1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat. Eur J Pharmacol 1984;106:271-283.
54. 1A receptor antagonists stimulate locomotion and induce behavioural changes (Abstract). Presented at the Fourth IUPHAR Satellite Meeting on Serotonin, Rotterdam, July, 23-25 1998;186.
55. Williams JT, Colmers WF, Pan ZZ. Voltage- and ligand-activated inwardly rectifying currents in dorsal raphe neurons in vivo. J Neurosci 1988;8:3499-3506.